Torrent Pharma Set to Launch Generic Semaglutide in India After 2026 Patent Expiry
Torrent Pharmaceuticals is preparing to launch both oral and injectable forms of semaglutide in India after Novo Nordisk’s patent expires in March 2026. The move positions Torrent as a leading player in the upcoming GLP-1 generics market. ✔️ Phase III Trials Approved Torrent secured regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) to […]